ArticleBMC nephrology2026
Multicenter study of the diagnostic value of erythrocyte morphology assessment by the EH-2090 for differentiation of glomerular and non-glomerular hematuria.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
objectivesTo address the limitations of microscopy and current automated instruments, we analyzed 11 red blood cell (RBC) morphological parameters generated by the EH-2090 analyzer. We aimed to identify dysmorphic RBCs associated with glomerular hematuria (GH), establish optimal diagnostic thresholds, and develop a predictive model for GH based on urinalysis features.
methodsA total of 597 hematuria samples were collected from patients across eight hospitals. The 11 RBC morphological parameters were compared with the final clinical diagnosis. The parameter yielding the largest area under the curve (AUC) was identified as being associated with GH, and its optimal diagnostic cutoff value was determined. Nine machine learning (ML) models were constructed. Receiver operating characteristic (ROC) and precision-recall (PR) curves were used to evaluate the models’ performances, and the SHapley Additive exPlanations (SHAP) method was used for visual analysis of the model with the optimal performance.
resultsThe results confirmed that acanthocytes, jagged RBCs, annular RBCs, and other dysmorphic RBCs offered the greatest clinical value for diagnosing GH. When the combined proportion of these four dysmorphic RBC types exceeded 26% of the total erythrocytes, the sensitivity and specificity for diagnosing GH were 92.2% and 81.7%, respectively, with an AUC of 0.907. Among the constructed diagnostic models for GH, the random forest (RF) model demonstrated the best performance, with an AUC of 0.960. Confusion matrix analysis of the validation set showed a sensitivity of 96.6% and a specificity of 85.9%.
conclusionThe EH-2090’s identification of dysmorphic RBCs demonstrated high sensitivity and accuracy in distinguishing GH from non-glomerular hematuria (NGH), offering a rapid, automated, and standardized detection method.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.